Evidence map›Paper›PMID 30619125›Full record

ArticleFrontiers in microbiology2018

Characterization of Sigma Factor Genes in

Yuriy Rebets, Konstantinos C Tsolis, Elísabet Eik Guðmundsdóttir, Joachim Koepff, Beata Wawiernia, Tobias Busche, Arne Bleidt, Liliya Horbal, Maksym Myronovskyi, Yousra Ahmed and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Transcription Unit Architecture ofFrontiers in microbiology · 2019
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Yuriy RebetsPharmazeutische Biotechnologie, Universität des Saarlandes, Saarbrücken, Germany.
Konstantinos C TsolisDepartment of Microbiology and Immunology, Rega Institute, KU Leuven, Leuven, Belgium.
Elísabet Eik GuðmundsdóttirMatis Ohf (MATIS), Reykjavik, Iceland.
Joachim KoepffIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich GmbH, Jülich, Germany.
Beata WawierniaMatis Ohf (MATIS), Reykjavik, Iceland.
Tobias BuscheCenter for Biotechnology, Bielefeld University, Bielefeld, Germany.
Arne BleidtIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich GmbH, Jülich, Germany.
Liliya HorbalPharmazeutische Biotechnologie, Universität des Saarlandes, Saarbrücken, Germany.
Maksym MyronovskyiPharmazeutische Biotechnologie, Universität des Saarlandes, Saarbrücken, Germany.
Yousra AhmedPharmazeutische Biotechnologie, Universität des Saarlandes, Saarbrücken, Germany.
Wolfgang WiechertIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich GmbH, Jülich, Germany.
Christian RückertCenter for Biotechnology, Bielefeld University, Bielefeld, Germany.
Mohamed B HamedDepartment of Microbiology and Immunology, Rega Institute, KU Leuven, Leuven, Belgium.
Bohdan BilykPharmazeutische Biotechnologie, Universität des Saarlandes, Saarbrücken, Germany.
Jozef AnnéDepartment of Microbiology and Immunology, Rega Institute, KU Leuven, Leuven, Belgium.
Ólafur FriðjónssonMatis Ohf (MATIS), Reykjavik, Iceland.
Jörn KalinowskiCenter for Biotechnology, Bielefeld University, Bielefeld, Germany.
Marco OldigesIBG-1: Biotechnology, Institute of Bio- and Geosciences, Forschungszentrum Jülich GmbH, Jülich, Germany.
Anastassios EconomouDepartment of Microbiology and Immunology, Rega Institute, KU Leuven, Leuven, Belgium.
Andriy LuzhetskyyPharmazeutische Biotechnologie, Universität des Saarlandes, Saarbrücken, Germany.
Saarland University · DEBielefeld University · DEForschungszentrum Jülich · DEMatís (Iceland) · ISKU Leuven · BERega Institute for Medical Research · BEHelmholtz Institute for Pharmaceutical Research Saarland · DERWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternative sigma factors control numerous aspects of bacterial life, including adaptation to physiological stresses, morphological development, persistence states and virulence. This is especially true for the physiologically complex actinobacteria. Here we report the development of a robust gene deletions system for

Indexed as

genomic librarysecretomicsstrain phenotypingStreptomyces lividanstranscriptomicsσ-factor

Identifiers

PMID30619125
PMCPMC6295645
OpenAlexW2905263720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.